Figure 1. Inducing ferroptosis enhanced the sensitivity of CRC to Oxaliplatin. (A, B) HCT116-Or (A) and H716 (B) cells were selected to construct the subcutaneous xenograft model of nude mice, so as to observe whether RSL3 with or without liproxstatin-1 would affect the suppression of oxaliplatin on colorectal cancer in vivo. Top, representative images of xenografted tumor in the indicated groups. Bottom, statistical results of growth of xenografted tumor with time. The data are presented as the mean ± SD, ***p < 0.001 (versus Model). (C, D) The cell (HCT116-Or (C) and H716 (D)) viability was measured to observe whether RSL3 with or without liproxstatin-1 would affect the suppression of oxaliplatin on colorectal cancer in vitro. The data are presented as the mean ± SD, ***p < 0.001 (versus Oxaliplatin).